Exact Mass: 376.1535

Exact Mass Matches: 376.1535

Found 16 metabolites which its exact mass value is equals to given mass value 376.1535, within given mass tolerance error 4.0E-5 dalton. Try search metabolite list with more accurate mass tolerance error 8.0E-6 dalton.

Entinostat

N-[[4-[(2-Aminoanilino)-oxomethyl]phenyl]methyl]carbamic acid 3-pyridinylmethyl ester

C21H20N4O3 (376.1535)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XH - Histone deacetylase (hdac) inhibitors D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents

   

Picotamide

4-Methoxy-N1,N3-bis[(pyridin-3-yl)methyl]benzene-1,3-dicarboximidate

C21H20N4O3 (376.1535)


B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors

   

(+)-Verrucine A

(+)-Verrucine A

C21H20N4O3 (376.1535)


   
   

Maybridge1_006713

Maybridge1_006713

C21H20N4O3 (376.1535)


   
   

Entinostat

Entinostat (MS-275)

C21H20N4O3 (376.1535)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XH - Histone deacetylase (hdac) inhibitors D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents

   

MS-275

N-[[4-[[(2-aminophenyl)amino]carbonyl]phenyl]methyl]-3-pyridinylmethyl ester, carbamic acid

C21H20N4O3 (376.1535)


   

[[5-[(Acetyloxy)methyl]-1-phenyl-1H-pyrazol-3-yl]methylene]phenylhydrazide acetic acid

[[5-[(Acetyloxy)methyl]-1-phenyl-1H-pyrazol-3-yl]methylene]phenylhydrazide acetic acid

C21H20N4O3 (376.1535)


   

4-(2-(4-Morpholinophenylamino)pyrimidin-4-yl)benzoic acid

4-(2-(4-Morpholinophenylamino)pyrimidin-4-yl)benzoic acid

C21H20N4O3 (376.1535)


   

Picotamide

Picotamide

C21H20N4O3 (376.1535)


B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors

   

N2-(2,5-dimethoxyphenyl)-N4-(2-furanylmethyl)quinazoline-2,4-diamine

N2-(2,5-dimethoxyphenyl)-N4-(2-furanylmethyl)quinazoline-2,4-diamine

C21H20N4O3 (376.1535)


   

3-[(6s,9s)-8,11-dioxo-6-(phenylamino)-6h,7h,9h-pyrido[2,1-b]quinazolin-9-yl]propanimidic acid

3-[(6s,9s)-8,11-dioxo-6-(phenylamino)-6h,7h,9h-pyrido[2,1-b]quinazolin-9-yl]propanimidic acid

C21H20N4O3 (376.1535)


   

3-[(1s,4r)-1-benzyl-3-hydroxy-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl]propanimidic acid

3-[(1s,4r)-1-benzyl-3-hydroxy-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl]propanimidic acid

C21H20N4O3 (376.1535)


   

3-{1-benzyl-3-hydroxy-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl}propanimidic acid

3-{1-benzyl-3-hydroxy-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl}propanimidic acid

C21H20N4O3 (376.1535)


   

3-[(1s,4s)-1-benzyl-3-hydroxy-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl]propanimidic acid

3-[(1s,4s)-1-benzyl-3-hydroxy-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl]propanimidic acid

C21H20N4O3 (376.1535)